INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.58B / 21S · 3 late79 trades$24.55M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SS
Sakhamuri SivakesavaChief Technical Officer
CRSPCRISPR Therapeutics AG
Grant or award
A—
90.0K sh
Nov 4, 2026Nov 6, 2026
Page 20 of 1649
← PrevNext →
traded Nov 4, 2026
+2d
SEC Form 4

Evidence

9
HR
Humphrey RachelDirector
PYXSPyxis Oncology, Inc.
Grant or award
A—
34.5K sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

9
MH
Machek HowardChief Accounting Officer
CENTCENTRAL GARDEN & PET CO
Option exercise
M—
4,968 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
SS
Schaefer Scott StephenChief Financial Officer
HLFHERBALIFE LTD.
Grant or award
A—
3,391 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
DJ
DeSimone JohnInterim CEO
HLFHERBALIFE LTD.
Grant or award
A—
34.6K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
GY
Garten YaelDirector
LEVILEVI STRAUSS & CO
Grant or award
A—
163 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FM
Foster Jon MEVP and COO
HCAHCA Healthcare, Inc.
Option exercise
M—
35.9K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BC
Badger Kyle CSVP, GC and Secretary
AGYSAGILYSYS INC
Grant or award
A—
3,099 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
AY
Abdelrahman Joe Ahmed YoussefChief Commercial Officer
AGYSAGILYSYS INC
Grant or award
A—
2,789 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
RJ
Robertson Chris JController
AGYSAGILYSYS INC
Grant or award
A—
922 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WD
Wood William David IIIChief Financial Officer
AGYSAGILYSYS INC
Grant or award
A—
5,143 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
PM
Pratt Ryan MichaelDirector, Chief Executive Officer
GUERGuerrilla RF, Inc.
Acquisition by will
W—
1,497 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Option exercise
M—
64.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Option exercise
M—
72.8K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Option exercise
M—
43.7K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
WJ
White Matthew JChief Financial Officer
LINLINDE PLC
Option exercise
M—
47.0K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
GM
Graney Kevin MDirector
LEUCENTRUS ENERGY CORP
Grant or award
A—
966 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
VH
Van Den Heuvel Will HExec Vice President - Sub
CINFCINCINNATI FINANCIAL CORP
Option exercise
M—
17.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
ST
Skiadas Anthony TEVP and CFO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
132 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
PK
Pou William K JrDirector
SSBSouthState Bank Corp
Grant or award
A$25K
239 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Option exercise
M—
41 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FP
Foster Jonathan P.Chief Financial Officer
MBRXMoleculin Biotech, Inc.
Tax withholding
F$84.6
10 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
TJ
Toothaker Bradley JDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A$10K
161 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
GG
Gouvalaris GeoffreyChief Accounting Officer
TRIPTripAdvisor, Inc.
Grant or award
A—
8,973 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SH
Schulman Daniel HDirector, CEO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$2,661
202 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
PA
Pinkley AprilCAO
SBSISOUTHSIDE BANCSHARES INC
Option exercise
M—
3,650 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
PA
Pinkley AprilCAO
SBSISOUTHSIDE BANCSHARES INC
Option exercise
M—
3,074 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
SJ
Smith Brian JDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A$11K
175 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
RV
Rockett Julie ValsaVP, Chief People Officer
MSMMSC INDUSTRIAL DIRECT CO INC
Tax withholding
F$4,174
36 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
SM
Sabag MarkSee "Remarks"
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Option exercise
M—
46.0K sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
BD
Bergwerk DovInterim Cheif Legal Officer
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Option exercise
M—
17.5K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BD
Bergwerk DovInterim Cheif Legal Officer
TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
Option exercise
M—
8,755 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
FF
Feldman Alan FDirector
NANAInland Real Estate Income Trust, Inc.
Grant or award
A—
2,368 sh
Nov 5, 2026Nov 6, 2026
traded Nov 5, 2026
+1dSEC Form 4

Evidence

9
HJ
Harte Neal JosephDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
LG
Legorreta Pablo G.Director, CEO, Chairman of the Board
RPRXRoyalty Pharma plc
Grant or award
A—
42.2K sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
LP
Lang James P.SVP - Enterprise Finance & CAO
SHWSHERWIN WILLIAMS CO
Option exercise
M—
620 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BH
Boodakian Stephen HarryDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
HS
Headley Jonathan ScottDirector
FUBOFuboTV Inc.
Option exercise
M—
2,410 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

9
MJ
Merritt Edward JDirector
WSBKWinchester Bancorp, Inc./MD/
Grant or award
A$41K
3,000 sh
Nov 4, 2026Nov 6, 2026
traded Nov 4, 2026
+2dSEC Form 4

Evidence

9
BP
Bird Andrew PeterDirector
FUBOFuboTV Inc.
Option exercise
M—
2,410 sh
Nov 6, 2026Nov 6, 2026
traded Nov 6, 2026
+0dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K